$1.5M sweet spot round size
Most of their 208 investments are in rounds between $12M and $38M
1996
Undisclosed raised $40M on November 16, 2022
Investors: Alta Partners
Novome Biotechnologies raised $44M on September 13, 2022
Investors: 5AM Ventures, Tencent, Touchdown Ventures, DCVC Bio, University of Minnesota, Navian Capital and Alta Partners
Paladina Health raised $164M on July 25, 2022
Investors: Endeavor Catalyst, Oak HC/FT and Alta Partners
DEM Biopharma, Inc. raised $70M on June 23, 2022
Investors: Astellas Venture Capital L.L.C., UTokyo Innovation Platform Co., Ltd., Longwood Fund, Insight Partners, Emerson Collective and Alta Partners
Kelonia Therapeutics raised $50M on April 28, 2022
Investors: Venrock, Horizons Ventures and Alta Partners
Free Market Health raised $14M on April 19, 2022
Investors: Alta Partners
Be Biopharma raised $130M on April 14, 2022
Investors: Takeda UK Limited, Bristol-Myers Squibb, UK, ARCH Venture Partners, Longwood Fund, Atlas Venture, RA Capital Management, L.P. and Alta Partners
Transcarent raised $200M on January 11, 2022
Investors: General Catalyst, GreatPoint Ventures and Alta Partners
ImmuneID raised $50M on June 23, 2021
Investors: Section 32, Longwood Fund, Tekla Capital Management, Xfund, ARCH Venture Partners, In-Q-Tel and Alta Partners
Transcarent raised $58M on June 10, 2021
Investors: Threshold Ventures, GreatPoint Ventures, General Catalyst, 7wire Ventures, Leaps by Bayer, Kleiner Perkins and Alta Partners